These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1491386)

  • 1. Nitrogen mustard as induction therapy for rheumatoid arthritis: clinical and immunologic effects.
    Danao T; Ropos T; Wilke W; Segal A; Calabrese L; Valenzuela R; Gragg L; Clough J
    J Rheumatol; 1992 Nov; 19(11):1683-6. PubMed ID: 1491386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
    Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF;
    J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.
    Davis JC; Fessler BJ; Tassiulas IO; McInnes IB; Yarboro CH; Pillemer S; Wilder R; Fleisher TA; Klippel JH; Boumpas DT
    J Rheumatol; 1998 Sep; 25(9):1694-704. PubMed ID: 9733448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy.
    Wolfe F; Pincus T; O'Dell J
    J Rheumatol; 2001 Jul; 28(7):1712-7. PubMed ID: 11469486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time?
    Plant MJ; O'Sullivan MM; Lewis PA; Camilleri JP; Coles EC; Jessop JD
    Rheumatology (Oxford); 2005 Sep; 44(9):1181-5. PubMed ID: 15972357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assessment of disease activity by patients with rheumatoid arthritis.
    Hanly JG; Mosher D; Sutton E; Weerasinghe S; Theriault D
    J Rheumatol; 1996 Sep; 23(9):1531-8. PubMed ID: 8877920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsed suppressive treatment in rheumatoid arthritis: intravenous methylprednisolone and nitrogen mustard.
    Danao T; Segal AM
    J Rheumatol; 1990 Jul; 17(7):893-9. PubMed ID: 2213755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
    Gordon P; West J; Jones H; Gibson T
    J Rheumatol; 2001 Nov; 28(11):2409-15. PubMed ID: 11708411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
    Yudoh K; Matsuno H; Nakazawa F; Yonezawa T; Kimura T
    Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses.
    Fekete A; Soos L; Szekanecz Z; Szabo Z; Szodoray P; Barath S; Lakos G
    J Autoimmun; 2007; 29(2-3):154-63. PubMed ID: 17826949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reevaluation of the symptom of morning stiffness.
    Hazes JM; Hayton R; Silman AJ
    J Rheumatol; 1993 Jul; 20(7):1138-42. PubMed ID: 8371206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
    Mease PJ; Revicki DA; Szechinski J; Greenwald M; Kivitz A; Barile-Fabris L; Kalsi J; Eames J; Leirisalo-Repo M
    J Rheumatol; 2008 Jan; 35(1):20-30. PubMed ID: 18050385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
    Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
    Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.
    Higashida J; Wun T; Schmidt S; Naguwa SM; Tuscano JM
    J Rheumatol; 2005 Nov; 32(11):2109-15. PubMed ID: 16265687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
    Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
    J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
    Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
    Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging: a valuable method for the detection of synovial inflammation in rheumatoid arthritis.
    Goupille P; Roulot B; Akoka S; Avimadje AM; Garaud P; Naccache L; Le Pape A; Valat JP
    J Rheumatol; 2001 Jan; 28(1):35-40. PubMed ID: 11196540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy.
    Comby E; Tanaff P; Mariotte D; Costentin-Pignol V; Marcelli C; Ballet JJ
    J Rheumatol; 2006 Jan; 33(1):24-30. PubMed ID: 16395746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
    Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
    J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.